Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Feb;65(2):544–550. doi: 10.1128/iai.65.2.544-550.1997

Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

N Mielcarek 1, J Cornette 1, A M Schacht 1, R J Pierce 1, C Locht 1, A Capron 1, G Riveau 1
PMCID: PMC176094  PMID: 9009311

Abstract

One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive investigation, and no live vector specifically designed for the respiratory mucosa is yet available. In this study we show that intranasal administration of the recombinant Bordetella pertussis BPGR60, producing the Schistosoma mansoni 28-kDa glutathione S-transferase (Sm28GST) protective antigen fused to filamentous hemagglutinin, induces priming in mice for the production of serum antibodies. In addition to significant levels of anti-Sm28GST immunoglobulin A (IgA) antibodies, high levels of anti-Sm28GST serum antibodies were obtained after intranasal boost with the purified antigen or infection with S. mansoni following intranasal priming with BPGR60. These antibodies were of the IgG1, IgG2a, and IgG2b isotypes, suggesting a mixed immune response. No priming was observed in animals that had received nonrecombinant B. pertussis or purified Sm28GST, indicating specific priming by BPGR60. This priming was also evident in immune protection against S. mansoni challenge. Significant protection against worm burden and egg output was obtained in mice primed with BPGR60 and intranasally boosted with purified Sm28GST. A lower but still significant degree of protection against egg output was also obtained in mice infected with a single dose of BPGR60. These results indicate that intranasal administration of recombinant B. pertussis can prime for serum antibody responses against a foreign antigen and for heterologous protection.

Full Text

The Full Text of this article is available as a PDF (203.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsbaugh D. F., Li Z. M., Shahin R. D. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection. Infect Immun. 1993 Apr;61(4):1447–1452. doi: 10.1128/iai.61.4.1447-1452.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antoine R., Locht C. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun. 1990 Jun;58(6):1518–1526. doi: 10.1128/iai.58.6.1518-1526.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balloul J. M., Grzych J. M., Pierce R. J., Capron A. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol. 1987 May 15;138(10):3448–3453. [PubMed] [Google Scholar]
  4. Boulanger D., Reid G. D., Sturrock R. F., Wolowczuk I., Balloul J. M., Grezel D., Pierce R. J., Otieno M. F., Guerret S., Grimaud J. A. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 1991 Sep;13(5):473–490. doi: 10.1111/j.1365-3024.1991.tb00545.x. [DOI] [PubMed] [Google Scholar]
  5. Boulanger D., Warter A., Trottein F., Mauny F., Brémond P., Audibert F., Couret D., Kadri S., Godin C., Sellin E. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni. Parasite Immunol. 1995 Jul;17(7):361–369. doi: 10.1111/j.1365-3024.1995.tb00903.x. [DOI] [PubMed] [Google Scholar]
  6. Capron A. R. Immunity to schistosomes. Curr Opin Immunol. 1992 Aug;4(4):419–424. doi: 10.1016/s0952-7915(06)80033-6. [DOI] [PubMed] [Google Scholar]
  7. Friedman R. L., Nordensson K., Wilson L., Akporiaye E. T., Yocum D. E. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect Immun. 1992 Nov;60(11):4578–4585. doi: 10.1128/iai.60.11.4578-4585.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A. E., Anemona A., Ciofi degli Atti M. L., Giammanco A., Panei P., Blackwelder W. C. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med. 1996 Feb 8;334(6):341–348. doi: 10.1056/NEJM199602083340601. [DOI] [PubMed] [Google Scholar]
  9. Grezel D., Capron M., Grzych J. M., Fontaine J., Lecocq J. P., Capron A. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur J Immunol. 1993 Feb;23(2):454–460. doi: 10.1002/eji.1830230223. [DOI] [PubMed] [Google Scholar]
  10. Grzych J. M., Grezel D., Xu C. B., Neyrinck J. L., Capron M., Ouma J. H., Butterworth A. E., Capron A. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol. 1993 Jan 15;150(2):527–535. [PubMed] [Google Scholar]
  11. Hannah J. H., Menozzi F. D., Renauld G., Locht C., Brennan M. J. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect Immun. 1994 Nov;62(11):5010–5019. doi: 10.1128/iai.62.11.5010-5019.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jacobs W. R., Jr, Snapper S. B., Lugosi L., Bloom B. R. Development of BCG as a recombinant vaccine vehicle. Curr Top Microbiol Immunol. 1990;155:153–160. doi: 10.1007/978-3-642-74983-4_11. [DOI] [PubMed] [Google Scholar]
  13. Kraehenbuhl J. P., Neutra M. R. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev. 1992 Oct;72(4):853–879. doi: 10.1152/physrev.1992.72.4.853. [DOI] [PubMed] [Google Scholar]
  14. Locht C., Bertin P., Menozzi F. D., Renauld G. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol. 1993 Aug;9(4):653–660. doi: 10.1111/j.1365-2958.1993.tb01725.x. [DOI] [PubMed] [Google Scholar]
  15. Long S. S., Welkon C. J., Clark J. L. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis. 1990 Mar;161(3):480–486. doi: 10.1093/infdis/161.3.480. [DOI] [PubMed] [Google Scholar]
  16. Menozzi F. D., Mutombo R., Renauld G., Gantiez C., Hannah J. H., Leininger E., Brennan M. J., Locht C. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun. 1994 Mar;62(3):769–778. doi: 10.1128/iai.62.3.769-778.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pankow W., von Wichert P. M cell in the immune system of the lung. Respiration. 1988;54(4):209–219. doi: 10.1159/000195527. [DOI] [PubMed] [Google Scholar]
  18. Redd S. C., Rumschlag H. S., Biellik R. J., Sanden G. N., Reimer C. B., Cohen M. L. Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine. J Clin Microbiol. 1988 Jul;26(7):1373–1377. doi: 10.1128/jcm.26.7.1373-1377.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Relman D., Tuomanen E., Falkow S., Golenbock D. T., Saukkonen K., Wright S. D. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell. 1990 Jun 29;61(7):1375–1382. doi: 10.1016/0092-8674(90)90701-f. [DOI] [PubMed] [Google Scholar]
  20. Renauld-Mongénie G., Mielcarek N., Cornette J., Schacht A. M., Capron A., Riveau G., Locht C. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7944–7949. doi: 10.1073/pnas.93.15.7944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med. 1991 May 1;173(5):1143–1149. doi: 10.1084/jem.173.5.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shahin R. D., Amsbaugh D. F., Leef M. F. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect Immun. 1992 Apr;60(4):1482–1488. doi: 10.1128/iai.60.4.1482-1488.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Smithers S. R., Terry R. J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965 Nov;55(4):695–700. doi: 10.1017/s0031182000086248. [DOI] [PubMed] [Google Scholar]
  24. Trottein F., Vaney M. C., Bachet B., Pierce R. J., Colloc'h N., Lecocq J. P., Capron A., Mornon J. P. Crystallization and preliminary X-ray diffraction studies of a protective cloned 28 kDa glutathione S-transferase from Schistosoma mansoni. J Mol Biol. 1992 Mar 20;224(2):515–518. doi: 10.1016/0022-2836(92)91013-f. [DOI] [PubMed] [Google Scholar]
  25. Tuomanen E., Towbin H., Rosenfelder G., Braun D., Larson G., Hansson G. C., Hill R. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med. 1988 Jul 1;168(1):267–277. doi: 10.1084/jem.168.1.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Walker R. I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 1994 Apr;12(5):387–400. doi: 10.1016/0264-410x(94)90112-0. [DOI] [PubMed] [Google Scholar]
  27. Weltzin R., Lucia-Jandris P., Michetti P., Fields B. N., Kraehenbuhl J. P., Neutra M. R. Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol. 1989 May;108(5):1673–1685. doi: 10.1083/jcb.108.5.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES